Skip to main content

HCA Healthcare Value Stock - Dividend - Research Selection

Hca holdings

ISIN: US40412C1018 , WKN: A1JFMW

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!

How our site works ...

✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month 
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of February 12, 2018, it owned and operated 179 hospitals and 120 freestanding surgery centers, and various other healthcare facilities in 20 states and the United Kingdom. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Is HCA (HCA) Using Outpatient Partnerships To Quietly Redefine Its Competitive Moat In Charleston?

2026-10-13
On 29 September 2026, Solis Mammography and HCA Healthcare’s Trident Hospital formed a joint venture to expand breast imaging services across the Charleston market, rebranding Trident’s existing program as Solis Mammography and planning further rollouts into additional HCA Healthcare facilities in the region. This move introduces Solis Mammography’s comprehensive breast health model into South Carolina, its 26th major market, potentially deepening HCA Healthcare’s outpatient footprint in the...

HCA Healthcare (HCA) Stock Could Trade At A Discount Following Its 96% Run

2026-10-13
HCA Healthcare has delivered strong multi year gains for shareholders, and the question now is whether the current share price is still supported by the cash the business can generate. With fresh headlines ranging from a tracking cookies lawsuit to asset sales and a payer dispute, investors are looking past the noise to what the company’s cash flows say about valuation. HCA Healthcare has returned about 96.0% over the past 3 years, which puts real weight on whether that performance lines up...

HCA Healthcare Is Too Healthy To Downgrade

2026-10-13
HCA Healthcare is a Buy supported by strong revenue growth and favorable demographic trends in healthcare demand. Read more on HCA stock here.

Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus

2026-10-12
HF Sinclair, Accenture and FirstCash post impressive gains as Zacks research portfolios highlight standout performers amid market uncertainty and shifting investor sentiment.

1 Value Stock Worth Your Attention and 2 We Avoid

2026-10-12
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $460

2026-10-12
TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $431 to $460.

Top 50 High-Quality Dividend Growth Stocks For October 2026

2026-10-11
Track 50 top dividend growth stocks: AMAT, DHI & HD climb as valuations shift.

HCA Healthcare (HCA) Could Be 3% Undervalued As Breast Imaging Expansion Continues

2026-10-07
Solis Mammography’s new joint venture with HCA Healthcare (HCA) Trident Hospital brings expanded breast imaging services to Charleston, as existing operations shift under the Solis banner with planned rollouts across more HCA facilities. Against this backdrop of targeted expansion in breast imaging, HCA Healthcare’s share price has gained 8.44% over the past month and 7.37% over the last 90 days. Longer term, total shareholder returns of 84.10% over three years and 91.61% over five years show...

RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

2026-10-07
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.

Knowtion Health Names Steven Huddleston Chief Executive Officer

2026-10-06
Knowtion Health, a healthcare company specializing in complex revenue recovery for providers, today named Steven Huddleston chief executive officer. Huddleston brings more than 25 years of experience in healthcare finance, strategy and revenue cycle leadership, including time spent as a health system finance executive. He has also built and led technology-enabled revenue cycle services companies, giving him a clear view of what health systems need from a partner.